Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Wall Street's Suddenly Sniffing Around This "Double Your Money Stock"

Aimmune Therapeutics Inc. (Nasdaq: AIMT) has been all over the place since shares of the Brisbane, Calif.-based food-allergy biotech soared 50% in its initial public offering (IPO) back in early August.

We anticipated the whipsawing, which is why we urged folks to use an "accumulate" strategy - and a time frame of two years or more.

Our view hasn't changed.

And now we have company.

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK